I have already provided Bibliography, all you have to do is just Summarize and Evaluate the source which i have also provided as well in the web link, just copy and paste the link so you can read through , summarize and then evaluation.
I also attached the a file with INSTRUCTIONS AND A SAMPLE OF HOW IT WILL LOOK LIKE WHEN YOU HAVE SUMMARIZED AND EVALUATED. 2 FILE, ONE IS "INSTRUCTIONS" AND THE WORK TO BE DONE IS THE FILE " ACTUAL PAPER TO BE DONE "
Read through the 5 sources (the web links )
Write up 1 summary paragraph with APA style in-text citations.4.
Write up 1 evaluation paragraph.Assemble the annotated bibliography of all 5 sources.
VI. Tasks to Complete: 1. Correct any APA style errors in your bibliographic entries from PPA#2. 2. Read through your 5 sources. 3. Write up 1 summary paragraph with APA style in-text citations. 4. Write up 1 evaluation paragraph. 5. Assemble your annotated bibliography of all 5 of your sources. · Each entry is worth .6 points each for 3 points total. · If you do not use in-text citations in your summary paragraph, you will lose up to .3 points per entry this occurs. I will take more minor deductions (.1 points) for other APA errors in each entry (THE SUMMARY AND EVALUATE SHOULD LOOK LIKE THIS BELOW) Correal, A. (2018, April 12). Overdose antidote is supposed to be easy to get: It’s not. The New York Times. Retrieved from https://www.nytimes.com Correal discusses in her article the expectations of people in obtaining naloxone from pharmacies in New York without the need for prescriptions and its reality (2018, p. 1). She says that people have expected to be able to acquire naloxone from retail pharmacies easily as the government and the city public awareness campaigns have stated that people are allowed to get naloxone from certain pharmacies without the need for prescription (Correal, 2018, p. 1). However, upon interviews with people and further research of The New York Times, the author reveals that pharmacies give different reasons as to why they could not dispense naloxone, some of which were about how the pharmacies do not have naloxone in stock, or that a prescription was needed while some pharmacies were confused about naloxone dispensing protocol (Correal, 2018, p. 1). These events lead Dr. Mary T. Bassett, the city’s health commissioner, to contact the stores in the list of participating pharmacies and send workers to clear the confusion regarding dispensing of naloxone which in turn lead different pharmacy chains to start reviewing their protocol with their personnel (Correal, 2018, p. 1). The article shows the efforts of the city and government in making the public aware about naloxone treatments for drug overdose as well as the challenges faced by the city in making naloxone publicly accessible. However, the article seems to criticize the city and its programs in addition to the pharmacies as the author constantly provided accounts of people not being able to acquire naloxone despite the city’s claims. Correal talks at length about the disappointing events of pharmacies not dispensing naloxone and only discusses briefly the reasons that pharmacies give as to why they could not dispense naloxone without prescriptions. The article could provide a better understanding of the situation if Correal also fully explains the pharmacies’ reasons and gives the pharmacies in question a chance to justify their reasons. Huang, X., Keyes, K. M., & Li, G. (2018). Increasing prescription opioid and heroin overdose mortality in the United States, 1999-2014: An age-period-cohort analysis. American Journal of Public Health, 108(1), 131-136. doi: 10.2105/AJPH.2017.304142. Retrieved from Academic Search Complete. Huang, Keyes, and Li determines whether drug overdose-related deaths, particularly those related to prescription opioid and heroin, are affected by variances over time that are either specific to an age group or birth cohort, or common in all age groups (2018, p. 131). The researchers use the data from the multiple-cause-of-death mortality files of the National Vital Statistics System and statistically analyzes the data (Huang, Keyes and Li, 2018, p. 132). The results show that people born between 1947 and 1964 experience higher mortality rates from both prescription opioid and heroin overdose and also, people born between 1979 and 1992 experience an increased risk 3 for heroin overdose death as compared to the reference cohort (individuals born in 1977-1978) (Huang, Keyes and Li, 2018, p. 135). Huang, Keyes, and Li points out the importance of intervention programs in these specific demographic groups in order to decrease drug overdose mortality rate (2018, p. 135). The article shows the statistics of deaths in the United States related to drug overdose and the trends relevant to it which highlights which demographic groups are important to pay attention to and therefore provides context which could help to solve both prescription opioid and heroin epidemics. The study also gives emphasis to the need for intervention programs which could serve as support for progress in the need for change. The article also addresses its deficiencies and limitations in its study and research which helps to spot areas which need work. Jones, C. M., Lurie, P. G., & Compton, W. M. (2016). Increase in naloxone prescriptions dispensed in US retail pharmacies since 2013. American Journal of Public Health, 106(4), 689-690. doi: 10.2015/AJPH.2016.303062. Retrieved from Academic Search Complete. Jones, Lurie, and Compton studies the trends of prescription of naloxone in the outpatient setting, retail pharmacies in particular, in the United States (2016, p. 689). The researchers use IMS Health’s National Prescription Audit in order to calculate the counts of naloxone prescriptions, which are classified into three groups (Evzio, the 2 milligram/2 millimeter naloxone formulation, other formulations), in US retail pharmacies for every quarter between July 2010 and June 2015 (Jones, Lurie and Compton, 2016, p. 689). In addition, they also determine the percentage of dispensed naloxone by the gender and age of the recipient, as well as the specialty of the provider (Jones, Lurie, and Compton, 2016, p. 689). As Jones, Lurie and Compton (2016) records, results show that naloxone prescriptions increased starting from 2014 coinciding with the first release of Evzio and the shift in the usage of the 2 milligram/2 millimeter formulation of naloxone (p. 689). In conclusion, Jones, Lurie and Compton states that the results show the complement between naloxone prescriptions in the outpatient setting and naloxone distribution through traditional community-based organizations (2016, p. 690). The study by Jones, Lurie and Compton presents the fact that prescriptions of naloxone, an antidote used to treat heroin overdose, have increased in the last few years. This shows that through the growth of naloxone prescriptions, the heroin epidemic can be fought; as by making naloxone accessible through retail pharmacies, the general public can be made aware of treatments available for overdose. However, the researchers only present the numbers from IMS’s data but does not analyze whether the increase of naloxone prescriptions have positive or negative effects on traditional community-based programs of naloxone distribution. Through this, Jones, Lurie and Compton could present a more concrete evidence on how naloxone prescriptions can aid community-based naloxone programs. Milloy, C. (2017, April 5). Word of overdoses can add to heroin's allure. The Washington Post. Retrieved from Lexis Nexis. Milloy speaks about the connection between a drug dealer and a drug addict and also states how overdoses work as advertisements for a drug by being proof of the potency of the drug which might entice a dealer’s customers (2017, p. 1). In the article, the author also mentions the attempts of Northern Virginia to crack heroin trafficking cases in addition to the difficulty of reducing the demand for drugs alongside with reducing its supply (Milloy, 2017, p. 1). Milloy also discusses the addictiveness of heroin and drugs and presents an example of a woman who could not escape the clutches of heroin (2017, p. 1). The article shows that even when efforts are being made, it would still be impossible to fully eradicate heroin addiction. It shows the threat of drug addiction and the problems that accompany it. As Milloy (2017) gives an example of the lengths a person would go to in order to get drugs, it serves as a reminder of the complexity of drug addiction, especially in regard to its demand and supply (p. 1). However, Milloy could present a more convincing argument if he discusses the efforts and difficulties in other states as this could intensify the necessity to reduce drug addiction. Shapiro, T. R. (2016, February 3). FBI film aims to reach kids before addiction does. The Washington Post. Retrieved from https://www.washingtonpost.com Shapiro talks about a film by the FBI and Drug Enforcement Administration that aims to address the epidemic surrounding opioids which includes both prescription opioids and heroin (2016, p. 1). The article states that the film, titled Chasing the Dragon, targets teenagers specially, contains testimonies from addicts who survived overdose, and is to be distributed by FBI and DEA to all their field offices in order to be used for educational purposes in classrooms nationwide (Shapiro, 2016, p. 1). Shapiro also presents the FBI’s concern over the shifting addiction of drug abusers from prescribed drugs to heroin and the increase of heroin abusers in the last few years (2016, p. 1). As Shapiro (2016) mentions in the article about the concern regarding drug addiction, the article provides information about the awareness of federal agencies and the steps they take in order to inform teenagers of drug addiction in the hopes of reducing and solving both opioid and heroin epidemics by convincing them of the detrimental effects of addiction (p. 1). The article also brings up Gov. Chris Christie and how she spoke about addiction as a health crisis (Shapiro, 2016, p. 1). However, the author has not clearly stated the governor’s relation to the film of the FBI and the DEA and it irrelevant to mention her at all.